Special Issue "Novel Nanoparticles for Targeted Delivery of Therapeutic Nucleic Acids"
Deadline for manuscript submissions: 31 October 2021.
Interests: gene therapy; RNA delivery; nucleic acid therapeutics; gene editing; nonviral vectors; cancer; respiratory disorders; ocular disorders; cardiovascular disorders; rare diseases
Interests: additive manufacturing (3D Printing & Bioprinting); drug delivery; electrospinning; microfluidics (micro/nano particle formulation & chip manufacturing); pharmaceutics
Special Issues and Collections in MDPI journals
Special Issue in Pharmaceutics: Nanotechnology Advances in Cancer Treatment
Special Issue in Materials: Polymeric Electrospun Nanofibers: Applications in Drug Delivery and Tissue Engineering
Special Issue in Polymers: Atomic Force Microscopy in Polymer Science
Special Issue in Pharmaceutics: 3D Printing of Pharmaceuticals and Drug Delivery Devices
Special Issue in Pharmaceutics: Recent Development of Electrospinning for Drug Delivery
Special Issue in Pharmaceutics: Recent Development of Electrospinning for Drug Delivery Volume II
Special Issue in Pharmaceutics: Microfluidics as a Tool for Drug Delivery
Topical Collection in Pharmaceutics: 3D Printing and Bioprinting Applications in Pharmaceutics
Special Issue in Molecules: Novel Formulations and Pharmaceutical Materials to Improve Therapeutic Outcomes for Patients. A Themed Issue Dedicated to Professor Ryan F. Donnelly
Special Issue in Coatings: Antimicrobial Coatings for Touch Surfaces and Air-Filters in the Wake of COVID-19
With the completion of the Human Genome project, there was great excitement about deciphering disease-causing genes. Since then, a number of them has been identified, but still, there are only few diseases which have seen some therapeutic outcomes. Over the years, many scientists have worked in genetic therapies, and only recently has some success been realised. However, there is lots of progress and new tools (including ex vivo and in vivo models), and there is increased hype that efficient and safe targeted molecular therapies will become successful for several disorders. Here, we are going to highlight the recent advances in Nanomedicine (novel liposomal, polymeric or nanoparticle formulations, etc.) with the hope that they will play a significant role in both improving the quality of life and curing patients.
This Special Issue welcomes original research papers and review articles dealing with the targeted therapeutic delivery of nucleic acids with novel nonviral nanocarriers.
Dr. Aristides D. Tagalakis
Dr. Dimitrios A. Lamprou
Dr. Cynthia Yu-Wai-Man
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gene delivery
- tumor therapy
- DNA delivery
- genome editing
- cell targeting
- gene therapy